TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 64.90
+2.20 (3.51%)
Sep 8, 2026, 12:50 PM CST
TaiMed Biologics Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 996.46 | 898.38 | 580.23 | 251.01 | 274.11 | 551.62 |
Short-Term Investments | 608 | 869.64 | 1,072 | 395.49 | 309.93 | 406.68 |
Trading Asset Securities | - | - | - | - | 58.75 | - |
Cash & Short-Term Investments | 1,604 | 1,768 | 1,652 | 646.5 | 642.79 | 958.3 |
Cash Growth | -2.57% | 7.00% | 155.58% | 0.58% | -32.92% | -20.21% |
Accounts Receivable | 47.95 | 79.06 | 103.02 | 160.49 | 98.24 | 157.78 |
Other Receivables | 53.87 | 48.41 | 31.3 | 28.16 | 25.49 | 35.41 |
Receivables | 101.82 | 127.48 | 134.31 | 188.65 | 123.73 | 193.19 |
Inventory | 1,314 | 1,399 | 1,569 | 1,271 | 1,389 | 1,177 |
Prepaid Expenses | 16.02 | 21.92 | 6.41 | 10.01 | 4.15 | 3.54 |
Other Current Assets | 22.19 | 6.28 | 31.16 | 35.63 | 5.08 | 2.59 |
Total Current Assets | 3,058 | 3,322 | 3,394 | 2,151 | 2,165 | 2,335 |
Property, Plant & Equipment | 812.2 | 807.39 | 857.4 | 908.26 | 957.74 | 1,011 |
Long-Term Investments | 15.93 | 15.72 | - | 0.9 | 43.44 | 232.63 |
Other Intangible Assets | 393.79 | 442.15 | 539.4 | 625.79 | 724.38 | 821.33 |
Other Long-Term Assets | 220.69 | 223.18 | 208.79 | 207.58 | 210.57 | 211.19 |
Total Assets | 4,501 | 4,811 | 4,999 | 3,894 | 4,101 | 4,611 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.11 | 81 | 0.76 | 13.5 | 0.09 | 122.58 |
Accrued Expenses | 47.22 | 16.66 | 11.63 | 7.49 | 39.39 | 51.64 |
Short-Term Debt | - | - | - | 200 | 200 | - |
Current Portion of Long-Term Debt | 28.14 | 27.84 | 27.24 | 26.97 | 14.32 | - |
Current Portion of Leases | 2.3 | 2.29 | 2.26 | 2.18 | 2.02 | 1.95 |
Current Unearned Revenue | 77.55 | 106.29 | 74.32 | 91.12 | 57.48 | 24.34 |
Other Current Liabilities | 40.3 | 19.43 | 18.56 | 19.92 | 16.57 | 24.57 |
Total Current Liabilities | 197.62 | 253.51 | 134.77 | 361.17 | 329.86 | 225.08 |
Long-Term Debt | 426.04 | 440.19 | 468.03 | 495.04 | 521.68 | 536 |
Long-Term Leases | 21.66 | 22.81 | 25.1 | 26.67 | 28.12 | 29.38 |
Long-Term Unearned Revenue | 179.17 | 236.55 | 347.53 | 444.04 | 505.6 | 877.9 |
Other Long-Term Liabilities | - | - | 0.92 | 0.92 | 0.92 | 0.87 |
Total Liabilities | 824.49 | 953.05 | 976.34 | 1,328 | 1,386 | 1,669 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,732 | 2,732 | 2,731 | 2,530 | 2,526 | 2,523 |
Additional Paid-In Capital | 2,475 | 2,469 | 2,452 | 986.67 | 945.45 | 925.14 |
Retained Earnings | -1,361 | -1,304 | -1,136 | -934.56 | -740.22 | -470.93 |
Comprehensive Income & Other | -36.26 | -38.88 | -23.89 | -16.13 | -15.83 | -35.97 |
Shareholders' Equity | 3,676 | 3,858 | 4,023 | 2,566 | 2,715 | 2,942 |
Total Liabilities & Equity | 4,501 | 4,811 | 4,999 | 3,894 | 4,101 | 4,611 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 478.14 | 493.12 | 522.63 | 750.86 | 766.14 | 567.32 |
Net Cash (Debt) | 1,126 | 1,275 | 1,130 | -104.35 | -123.35 | 390.98 |
Net Cash Growth | -1.10% | 12.86% | - | - | - | -38.12% |
Net Cash Per Share | 4.13 | 4.67 | 4.21 | -0.41 | -0.49 | 1.55 |
Filing Date Shares Outstanding | 273.2 | 273.2 | 273.08 | 253.01 | 252.55 | 252.33 |
Total Common Shares Outstanding | 273.2 | 273.2 | 273.08 | 253.01 | 252.55 | 252.33 |
Working Capital | 2,861 | 3,069 | 3,259 | 1,790 | 1,835 | 2,110 |
Book Value Per Share | 13.46 | 14.12 | 14.73 | 10.14 | 10.75 | 11.66 |
Tangible Book Value | 3,283 | 3,416 | 3,484 | 1,940 | 1,991 | 2,120 |
Tangible Book Value Per Share | 12.02 | 12.50 | 12.76 | 7.67 | 7.88 | 8.40 |
Land | 194.61 | 194.61 | 194.61 | 194.61 | 194.61 | 194.61 |
Buildings | 498.48 | 497.93 | 495.41 | 493.95 | 493.54 | 493.12 |
Machinery | 491.13 | 458.82 | 457.35 | 455.56 | 450.03 | 446.9 |
Leasehold Improvements | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 |